Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

LdrB Toxin with In Vitro and In Vivo Antitumor Activity as a Potential Tool for Cancer Gene Therapy.

Jiménez-Martínez Y, Griñán-Lisón C, Khaldy H, Martín A, Cambrils A, Ibáñez Grau A, Jiménez G, Marchal JA, Boulaiz H.

Cancers (Basel). 2019 Jul 20;11(7). pii: E1016. doi: 10.3390/cancers11071016.

2.

Mitochondrial regulation by melatonin and its metabolites.

Acuña-Castroviejo D, Escames G, León J, Carazo A, Khaldy H.

Adv Exp Med Biol. 2003;527:549-57. Review.

PMID:
15206773
3.

Changes in iNOS activity, oxidative stress and melatonin levels in hypertensive patients treated with lacidipine.

Escames G, Khaldy H, León J, González L, Acuña-Castroviejo D.

J Hypertens. 2004 Mar;22(3):629-35.

PMID:
15076170
4.

Changes in brain amino acids and nitric oxide after melatonin administration in rats with pentylenetetrazole-induced seizures.

Bikjdaouene L, Escames G, León J, Ferrer JM, Khaldy H, Vives F, Acuña-Castroviejo D.

J Pineal Res. 2003 Aug;35(1):54-60.

PMID:
12823614
5.

Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion.

Khaldy H, Escames G, León J, Bikjdaouene L, Acuña-Castroviejo D.

Neurobiol Aging. 2003 May-Jun;24(3):491-500.

PMID:
12600724
6.

Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment.

Khaldy H, León J, Escames G, Bikjdaouene L, García JJ, Acuña-Castroviejo D.

Neuroendocrinology. 2002 Mar;75(3):201-8.

PMID:
11914592

Supplemental Content

Loading ...
Support Center